FIRM FIXED PRICE

PINE PHARMACEUTICALS LLC - NIDDK: PROCUREMENT OF INTRAVENOUS STABLE ISOTOPE GLUCOSE (6,6 DEUTERATED GLUCOSE) FOR METABOLIC RESEARCH. NONSEVERABLE.

PIID: 75N94026F00001
Signed Date: Dec 15, 2025Effective Date: Dec 18, 2025End Date: Closed on May 31, 2026
Award $
$92K
Vendor
PINE PHARMACEUTICALS LLC
NAICS
325412
Signed Date
Dec 15, 2025

Key Details

Dollars Obligated
$91,897.7
Base & All Options
$91,897.7
Awarding Sub-Agency
National Institutes of Health
Product Service Code
6505 - DRUGS AND BIOLOGICALS
Extent Competed
COMPETED UNDER SAP
Place of Performance
TONAWANDA, NY, 141505837, CD-NY-26

Description

NIDDK: PROCUREMENT OF INTRAVENOUS STABLE ISOTOPE GLUCOSE (6,6 DEUTERATED GLUCOSE) FOR METABOLIC RESEARCH. NONSEVERABLE.

Context & Analysis

On Dec 15, 2025, Department of Health and Human Services obligated $91,897.7 to PINE PHARMACEUTICALS LLC for niddk: procurement of intravenous stable isotope glucose (6,6 deuterated glucose) for metabolic research. nonseverable.. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: competed under sap. Performance is located in TONAWANDA, NY. This award is one of several similar procurements from Department of Health and Human Services under NAICS 325412 — related awards are listed below.

Contractor Information

UEI: TCJXKNYD6WL5
CAGE Code: 7JZE9
Location: TONAWANDA, NY
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related